New research reveals why dramatic weight loss reshapes more than your waistline — and what it’s teaching us about facial aging.
For years, the beauty world followed one simple rule: shrink the body, shrink the face. But the rise of GLP-1 medications like Ozempic, Wegovy, Mounjaro and Zepbound is upending that logic entirely.
As more people drop significant weight, many are noticing something unexpected staring back at them in the mirror — flatter cheeks, hollowed temples, sunken under-eyes and more pronounced lines around the mouth and jaw. Social media dubbed it “Ozempic face,” though the term is a bit of a misnomer. This isn’t necessarily exclusive to Ozempic or even to GLP-1 drugs. It’s largely a byproduct of losing a substantial amount of body fat in a short window of time.
Still, the conversation has pulled back the curtain on something the beauty industry has danced around for decades: facial fullness plays a major role in how youthful a face appears.
Why Ozempic Changes More Than Your Body
The face isn’t just skin draped over bone. It’s built from layered fat, muscle and connective tissue that all contribute to its shape. When someone sheds a large amount of weight, that facial fat can disappear right along with fat everywhere else on the body, leaving behind a deflated or sunken look.
The Science Behind Facial Volume Loss
A 2025 study from Vanderbilt University Medical Center provided some of the first objective data on the phenomenon. Researchers analyzed CT and MRI scans from 20 people taking GLP-1 medications who had lost an average of about 24 pounds. Their total midface volume decreased by a median of 9%, with the largest reduction occurring in superficial facial fat. The researchers estimated that midfacial volume decreased by about 7% for every 22 pounds of total weight lost.
That said, results vary widely from person to person. Age, genetics, skin elasticity, how fast the weight comes off and where someone naturally stores fat all factor in. A 2025 systematic review even noted there isn’t strong evidence that GLP-1 drugs specifically target facial fat — it may simply be a natural response to significant weight loss itself.
Beauty’s Renewed Obsession With Fullness
For much of the last two decades, sculpted cheekbones and slimmed-down faces were the beauty standard, fueling everything from contouring tutorials to buccal fat removal. But facial anatomy tells a more layered story. When certain fat compartments shrink, shadows deepen and the transitions between facial features sharpen — hence the hollow cheeks and more visible nasolabial folds people are reporting.
The American Academy of Dermatology notes that patients taking GLP-1 medications may notice less facial plumpness, sagging skin, wrinkles and a crepe-like texture. Dermatologists say these changes are partly related to rapid weight loss, while GLP-1 medications may also affect collagen, muscle and fat cells. For patients bothered by the changes, dermatologists may use treatments such as dermal fillers and fat transfer to restore lost facial volume. The AAD also cautions against overdoing fillers, noting that a conservative approach tends to produce more natural-looking results.
What This Means If You Have Melanin-Rich Skin
Facial aging doesn’t show up the same way across every skin tone. Melanin-rich skin tends to age with different pigmentation and textural patterns than lighter skin, meaning priorities can differ from person to person — some may notice uneven tone first, others cheek volume or under-eye hollowing. Because certain cosmetic treatments carry a higher risk of post-inflammatory hyperpigmentation on deeper skin, individualized care matters more than ever.
Should This Change Your Weight-Loss Plans?
Not necessarily. Framing this shift purely as a beauty issue overlooks the fact that many people take GLP-1 medications as part of treatment for obesity, diabetes and other health concerns. A 2026 analysis of 1,226 patient-reported outcomes found that complaints of sagging skin, facial volume loss and hair thinning became more common as the percentage of body weight lost increased. Among the 325 respondents who reported losing more than 20% of their body weight, 50% reported decreased facial volume. Because the findings were based on self-reported experiences, however, they cannot establish that the medications themselves caused these changes.
The bigger takeaway isn’t about the drugs — it’s about how our understanding of beauty is evolving. A face doesn’t need to be perfectly smooth or completely full to look healthy. What’s changing is the recognition that transformation shows up in places a scale can’t measure, and that’s reshaping how the beauty world talks about aging altogether.
